甘糖酯与全反式维甲酸合用防治APL并发DIC疗效观察  

THERAPEUTIC OBSERVATION OF COMBINE USE PGMS AND ALL-TRANS RETINOIC ACID IN TREATING APL COMPLICATIED BY DIC

作　　者：宋红霞[1] 王福安[1] 于全军[1] 

机构地区：[1]威海市文登中心医院血液内科,威海264400

出　　处：《中国海洋药物》2000年第6期42-44,共3页Chinese Journal of Marine Drugs

摘　　要：甘糖酯与全反式维甲酸 ( ATRA)合用治疗急性早幼粒细胞白血病 ( APL ) 2 0例 ,完全缓解率 90 % ,较单用 ATRA治疗可明显降低 ATRA诱导分化治疗中弥散性血管内凝血 ( DIC)的发生率及与 DIC相关的死亡率。cases of acute promyelocytic leukemia (APL) were treated with drugs of all trans retinoic acid (ATRA) and Proplylene glucol mannurate sulfate (PGMS).Complete Remission rate was 90%. Because of using Proplylene glucol mannurate sulfate (PGMS), the rate of DIC and the rate of death were decreased.

关 键 词：甘糖酯 全反式维甲酸 急性早幼粒细胞白血病 弥散性血管内凝血 

分 类 号：R733.710.5[医药卫生—肿瘤] R554.805[医药卫生—临床医学]